5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.07▼ | 1.07▼ | 1.07▼ | 1.06▲ | 1.07▼ |
MA10 | 1.07▼ | 1.07▼ | 1.07▼ | 1.07▲ | 1.11▼ |
MA20 | 1.07▲ | 1.07▲ | 1.07▼ | 1.09▼ | 1.21▼ |
MA50 | 1.08▼ | 1.08▼ | 1.09▼ | 1.14▼ | 1.22▼ |
MA100 | 1.10▼ | 1.10▼ | 1.10▼ | 1.22▼ | 5.62▼ |
MA200 | 1.11▼ | 1.14▼ | 1.17▼ | 1.21▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.002▲ | 0.002▲ | 0.001▲ | 0.016▲ |
RSI | 49.387▼ | 48.595▼ | 47.906▼ | 44.973▼ | 38.631▼ |
STOCH | 44.167 | 46.667 | 46.667 | 13.889▼ | 25.078 |
WILL %R | -60.000 | -60.000 | -60.000 | -85.714▼ | -81.250▼ |
CCI | -7.735 | 11.814 | 0.841 | -46.680 | -87.879 |
Monday, June 30, 2025 04:00 AM
MENLO PARK, Calif.--(BUSINESS WIRE)-- AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company developing novel small molecule therapeutics derived from its boron ...
|
Thursday, June 19, 2025 05:01 PM
MENLO PARK, Calif., May 29, 2025--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron ...
|
Thursday, June 05, 2025 07:05 AM
Houston-based Stellar Bancorp Inc. (NYSE: STEL) will dual list its stock on NYSE Texas, the New York Stock Exchange’s newly launched fully electronic equities exchange based in Dallas.Stellar ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
08/07/25 | 1.085 | 1.085 | 1.07 | 1.07 | 60,419 |
07/07/25 | 1.0968 | 1.0999 | 1.05 | 1.05 | 69,399 |
03/07/25 | 1.05 | 1.11 | 1.05 | 1.05 | 66,614 |
02/07/25 | 1.05 | 1.1052 | 1.05 | 1.08 | 66,720 |
01/07/25 | 1.05 | 1.07 | 1.05 | 1.05 | 61,585 |
30/06/25 | 1.08 | 1.10 | 1.05 | 1.06 | 110,178 |
27/06/25 | 1.09 | 1.09 | 1.07 | 1.08 | 51,234 |
26/06/25 | 1.09 | 1.10 | 1.07 | 1.08 | 91,409 |
25/06/25 | 1.07 | 1.105 | 1.07 | 1.10 | 571,449 |
24/06/25 | 1.09 | 1.10 | 1.07 | 1.08 | 57,582 |
|
|
||||
|
|
||||
|
|